CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade

Blood

Volumn 94, Issue 4, 1999, Pages 1382-1392

  Tuscano, Joseph M ^b   Riva, Agostino ^b   Toscano, Salvador N ^b   Tedder, Thomas F ^b   Kehrl, John H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD22 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; B LYMPHOCYTE; CROSS LINKING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033566993     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1382     Document Type: Article

References (58)

1. Crocker PR, Mucklow S, Bouckson V, McWilliam A, Willis AC, Gordon S, Milon G, Kelm S, Bradfield P: Sialoadhesion, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains. EMBOJ 13:4490, 1994
2. Kelm S, Pelz A, Schauer R, Filbin MT, Tang S, deBellard ME, Schnaar RL, Mahoney JA, Hartnell A, Bradfield P: Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. CurrBiol 4:965, 1994
3. Tedder TF, Tuscano J, Sato S, Kehrl JH: CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling, Annu Rev Immunol 15:481, 1997
4. Stamenkovic I, Seed B: The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 345:74, 1990
5. Wilson, GL Fox CH, Fauci AS, Kehrl JH: cDNA cloning of the B cell membrane protein CD22: A mediator of B-B cell interactions. J Exp Med 173:137, 1991
6. Engel P, Nojima Y, Rothstein D, Zhou LJ, Wilson GL, Kehrl JH, Tedder TF: The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J Immunol 150:4719, 1993
7. Leprince C, Draves KE, Geahlen RL, Ledbetter JA, Clark EA: CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc Natl Acad Sci USA 90:3236, 1993
8. Cambier JC: New nomenclature for the Reth motif (or ARH1/TAM/ ARAM/YXX). Immunol Today 16:110, 1995
9. Pleiman CM, D'Ambrosio D, Cambier JC: The B-cell antigen receptor complex: Structure and signal transduction. Immunol Today 5:393, 1994
10. Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors. Cell 76:263, 1994
11. Law C-L, Sidorenko SP, Chandran KA, Zhao Z, Shen S-H, Fischer EH, Clark EA: CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-γ1 upon B cell activation. J Exp Med 183:547, 1996
12. Tuscano JM, Engel P, Tedder TF, Aggarwal A, Kehrl JH: Involvement of p72 Syk kinase, p53/56 Lyn kinase, and PI-3 kinase in signal transduction via the human B lymphocyte antigen CD22. Eur J Immunol 26:1246, 1996
13. Tuscano JM, Tedder TF, Kehrl JH: Engagement of CD22 triggers a potent stimulatory signal for B-cells and blocking a CD22/CD22L interaction impairs T-cell proliferation. Blood 87:4723, 1996
14. Pezzuto A, Rabinovitch PS, Dorken B, Moldenhaur G, Clark EA: Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin. J Immunol 140:1791, 1988
15. Pezzuto A, Dorken B, Moldenhaur G, Clark EA: Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22 Bp 130/140. J Immunol 138:98, 1987
16. Stoddart A, Ray RJ: Analysis of murine CD22 during B cell development: CD22 is expressed on B cell progenitors prior to IgM. Int Immunol 10:1571, 1997
17. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J-P, Long EO: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4:77, 1996
18. Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT: A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269:242, 1995
19. Campbell MA, Klinman NR: Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur J Immunol 25:1573, 1995
20. Lankester AC, VanSchijndel GM, VanLier RA: Hematopoietic cell phosphatase in recruited to CD22 following B cell antigen receptor ligation. J Biol Chem 270:20305, 1995
21. O'KeefeTL, Williams GT, Davies SL, Neuberger MS: Hyperresponsive B cells in CD22-deficient mice. Science 274:798, 1996
22. Otipoby KL, Anderson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perimutter RM, Law C-L, Clark EA: CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384:634, 1996
23. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang MLK, Tedder TF: CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 5:551, 1996
24. Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC: CD22 is a negative regulator of B-cell receptor signaling. Curr Biol 7:133, 1997
25. Sato S, Jansen PJ, Tedder TF: CD19 and CD22 reciprocally regulate Vav tyrosine phosphorylation during B lymphocyte signaling. Proc Natl Acad Sci USA 94:13158, 1997
26. Tooze RM, Doody GM, Fearon DT: Counterregulation by the coreceptors CD 19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 7:59, 1997
27. Franklin RA, Tordai A, Mazer B, Terada N, Lucas JJ, Gelfand EW: Activation of MAP2-kinase in B lymphocytes by calcium ionophores. J Immunol 153:4890, 1994
28. Berberich I, Shu G, Siebelt F, Woodgett JR, Kyriakis JM, Clark EA: Cross-linking CD40 on B cell preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J 15:92, 1996
29. Riva A, Wilson GL, Kehrl JH: In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an SP1/Egr-1 binding site and a novel site termed the PyG box. J Immunol 159:1284, 1997
30. Darzynkiewicz Z, Crissman HA, Robinson JR: Methods in Cell Biology: Flow Cytometry (ed 2). San Diego, CA, Academic, 1994
31. Aiello A, Delia D, Borrello MG, Bissoni D, Giardini R, Fontanella E, Pezzella F, Pulford K, Pierotti M, Della Porta G: Flow cyometric detection of the mitochondrial Bcl-2 protein in normal and neoplastic lymphoid cells. Cytometry 13:502, 1992
32. Farahat N, van der Plas D, Praxedes M, Morilla R, Matutes E, Catovsky D: Demonstration of cytoplasmic and nuclear antigens in acute leukemia using flow cytometry. J Clin Pathol 47:843, 1994
33. Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG, Clark EA: Involvement of the stress-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc Natl Acad Sci USA 93:13814, 1996
34. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 9:726, 1995
35. Cambier JC, Pleiman CM, Clark MR: Signal transduction by the B cell antigen receptor and its coreceptors. Annu Rev Immunol 112:457, 1994
36. Huo L, Rothstein TL: Receptor-specific induction of individual AP-1 components in B lymphocytes. J Immunol 154:3300, 1995
37. Karin M, Hunter T: Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus. Curr Biol 5:7477, 1995
38. Xia Z, Dickens M, Raingeaug J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326, 1995
39. Wilson DJ, Fortner KA, Lynch DA, Mattingly RR, Posada JA, Budd RC: JNK but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur J Immunol 26:989, 1996
40. Yao XR, Scott DW: Antisence oligodeoxynucleotides to the BIk tyrosine kinase prevent anti-μ-chain-mediated growth inhibition and apoptosis in B cell lymphomas. Proc Natl Acad Sci USA 90:7946, 1993
41. Hibner U Benhamou LE, Haury M, Cazenave PA, Sarthou P: Signaling of programmed cell death induction in WEHI-231 B lymphoma cells. Eur J Immunol 23:2821, 1993
42. Caouchi N, Vazquez A, Galanaud P, Leprince C: B cell antigen receptor-mediated apoptosis: Importance of accessory molecules CD 19 and CD22 and of surface IgM crosslinking. J Immunol 154:3096, 1995
43. Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P: Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO 16:3563, 1998
44. Clerk A, Sugden PH: The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-jun N-terminal kinases (SAPKs/JNKs). FEES Lett 426:93, 1998
45. Andersson ML, Stam NJ, Klein G, Ploegh HL, Masucci MG: Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells. Int J Cancer 47:544, 1991
46. Sarmay G, Koncz G, Gergely J: Intergration of activatory and inhibitory signals in human B-cells. Immunol Lett 54:93, 1996
47. Nunez G, Merino R, Grillot D, Gonzalez-Garcia M: Bcl-2 and Bcl-x: Regulatory switches for lymphoid death and survival. Immunol Today 15:582, 1994
48. Tuscano JM, Druey KM, Riva A, Pena J, Thompson CB, Kehrl JH: Bcl-x rather than Bcl-2 mediates CD40-dependent centiocyte survival in the germinal center. Blood 88:1359, 1996
49. Schneider TJ, Didier G, Fotte LC, Nunez GE, Rothstein TL: Bcl-x protects primary B cells against Fas-mediated apoptosis. J Immunol 159:4834, 1997
50. L, and Mcl-1 expression. Cell Immunol 178:33, 1997
51. L and Mcl-1. Blood 89:4415, 1997
52. Riekmann P, JM Tuscano, JH Kehrl, Tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in B lymphocyte function. Methods 1:128, 1997
53. Pombo CM, Kehrl JH, Sanchez I, Katz P, Avruch J, Zons LI, Woodget JR, Force T, Kyriakis JM: Activation of the SAPK pathway by the human STE20 homolog germinal centre kinase. Nature 377:750, 1995
54. Shi CS, Kehrl JH: Activation of the stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-κB by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2-and germinal center kinase-dependent pathway. J Biol Chem 272:32102, 1997
55. Diener K, Xuhong SW, Chen C, Meyer CF, Keesler G, Zukowski M, Tan TH, Yao Z: Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase. Proc Natl Acad Sci USA 94:9687, 1997
56. Parry SL, Hasbold J, Holman M, Klaus GGB: Hypercrosslinking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by co-stimulation with IL-4 and anti-CD40. J Immunol 152:2821, 1994
57. Grumont RJ, Rourke IJ, O'Rielly LA, Strasser A, Miyake K, Sha W, Gerondakis S: B lymphocytes differentially use the Rel and nuclear factor 6B1 (NF-6B) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med 187:663, 1998
58. Marshall CJ: Specificity or receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179, 1995